Baijin Life Science HoldingsMNNGF 34 PB Ratio is 3.26 as of Jul. 01, 2026, which is 14% below its 10-year median of 3.78. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.06. The stock has 4 warning signs investors should review. Among 1,072 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 84.05% on this metric.
The historical rank and industry rank for Baijin Life Science Holdings's PB Ratio or its related term are showing as below:
MNNGF'
s PB Ratio Range Over the Past 10 Years
Min: 0.26 Med: 3.78 Max: 11.06
Current: 4.62
During the past 12 years, Baijin Life Science Holdings's highest PB Ratio was 11.06. The lowest was 0.26. And the median was 3.78.
MNNGF's PB Ratio is ranked worse than 84.05% of 1072
companies
in the Retail - Cyclical industry
Industry Median: 1.46
vs MNNGF: 4.62
During the past 12 months, Baijin Life Science Holdings's average Book Value Per Share Growth Rate was 42.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 18.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -12.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -28.60% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Baijin Life Science Holdings was 18.90% per year. The lowest was -54.10% per year. And the median was -15.90% per year.
Back to Basics: PB Ratio
Baijin Life Science Holdings (OTCPK:MNNGF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Baijin Life Science Holdings PB Ratio Related Terms
Baijin Life Science Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings PB Ratio vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Baijin Life Science Holdings (MNNGF) has a PB Ratio of 3.26 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Baijin Life Science Holdings and its competitors. This is 14% below median its historical median of 3.78. Over the past decade, Baijin Life Science Holdings' PB Ratio has ranged from 0.26 to 11.06. According to the industry distribution chart, Baijin Life Science Holdings ranks #901 out of 1072 companies in the Retail - Cyclical industry, placing it in the top 84%.
Is Baijin Life Science Holdings' PB Ratio too high?
Baijin Life Science Holdings' current PB Ratio of 3.26 is 14% below median its 10-year median of 3.78. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 11.06. The Retail - Cyclical industry median PB Ratio is 1.46. Baijin Life Science Holdings' value of 3.26 is 123.3% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #901 out of 1072 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' PB Ratio compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #901 out of 1072 companies for PB Ratio. This places Baijin Life Science Holdings in the lower half of its industry. The industry median PB Ratio is 1.46. Baijin Life Science Holdings' value of 3.26 is 123.3% above this benchmark. Historically, Baijin Life Science Holdings' own PB Ratio has ranged from 0.26 to 11.06 over the past decade. While the company's 10-year median is 3.78 vs. the industry median of 1.46, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Retail - Cyclical company?
The median PB Ratio among Retail - Cyclical companies is 1.46, based on 1,072 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current PB Ratio of 3.26 is 123.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median PB Ratio is 1.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current PB Ratio is 3.26, which is 14% below median its own 10-year median of 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current PB Ratio of 3.26. The stock's GF Value™ is $0.06, compared to a current price of $0.08 — trading 25% above its estimated fair value. The current PB Ratio is 3.26, which is 14% below median its 10-year median of 3.78 and 123.3% above the Retail - Cyclical industry median of 1.46. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current PB Ratio is 3.26 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 25% above its estimated GF Value™ of $0.06.
Key valuation signals for MNNGF:
PB Ratio: 3.26 (14% below median its 10-year median of 3.78)
GF Value™: $0.06 vs. price of $0.08 (25% above fair value)
Industry Position: 123.3% above the Retail - Cyclical median (#901 of 1072)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
